Recorded device evidence

GETINGE 400HC-E / SERIES STEAM STERILIZER (K122071): indications, design and recorded evidence

The acquired K122071 file contains product-specific indications and users, design and operating principle, performance evidence actually described, clinical evidence or its stated absence sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-08. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 28 selected decisions under primary code FLE. 28 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 92.5, median 136.0, upper quartile 212.2. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K122071 ↗ · this pageGETINGE 400HC-E / SERIES STEAM STERILIZER2012-07-16 → 2013-03-12239Traditional
K261055 ↗AMSCO 700 Steam Sterilizer2026-03-31 → 2026-06-2485Traditional
K260254 ↗Enbio PRO2026-01-27 → 2026-02-2630Traditional
K252307 ↗Getinge GSS67N Series Steam Sterilizer2025-07-24 → 2026-01-22182Traditional
K250168 ↗Life Ultra 25L Tabletop Mono Chamber Steam Sterilizer2025-01-21 → 2025-12-30343Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K122071 · PDF page 4 ↗ Source 2

Read this statement in the original PDF; no complete statement fits the short excerpt.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K122071 · PDF page 1 ↗ Source 3

The     Getinge       400HC-EI500HC-E                               Series     Steam          Sterilizer     is designed     for     sterilization       of     heat
and            moisture         stable     materials     used           in healthcare     facilities.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K122071 · PDF page 5 ↗ Source 4

Factory              recommended               cycles       were            tested           per           industry          standards           and           guidelines          and
effectiveness                 of             sterilizer              function                was                  demonstrated                        by              complete                    kill                 of           biological
indicators.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Clinical evidence or its stated absence

K122071 · PDF page 6 ↗ Source 5

No         clinical      data         is required      for  this         device     classification      submission.

Compare with your product: Preserve whether the summary describes clinical evidence or says none was performed. This recorded case does not determine whether your product needs clinical evidence.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK122071 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryGETINGE 400HC-E / SERIES STEAM STERILIZER [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantGetinge Sourcing, LLC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeFLE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2013-03-12 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2012-07-16 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

  4. Clinical evidence or its stated absence — what differs in our product?

    Preserve whether the summary describes clinical evidence or says none was performed. This recorded case does not determine whether your product needs clinical evidence.

    Useful evidence: Your proposed claims and supporting evidence, plus a reviewed rationale for clinical-evidence needs.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[20613] · record c82b6926a01f0977c724bb5f6086f50dbfbc60fa46991b9fb248b26a4bb3968e
  • [6] Complete results array / fda-decision-context:K122071 · record whole dataset partition

FDA 510(k) summary — K122071 ↗

Thu, 11 Apr 2013 16:52:37 GMT · retrieved 2026-10-08

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot cacb894c59baa450aba137be7e3cceaad41c218f274c82f36cea5fa73f360c38

  • [2] PDF page 4 · record e11abffaf62bc8fdb60497175f80b2c784d34cb45f68d7838d536a65a57af2f6
  • [3] PDF page 1 · record 599abf998cf4a7690405b902d2dfc92f4a850660fc76da9a3c1864dd98c5d5be
  • [4] PDF page 5 · record d548ca371cd56ecf842041d555f89c0ded58408acf5b63b4252068174a00fb54
  • [5] PDF page 6 · record 69fa025545a04f2f7c1817544cd106f5e10fc7eccac6be826e2a8f3eda1d2d43

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Sterilization + Microbiology Validation